CTRI/2024/06/069492Not yet recruitingPhase 2
A Pilot clinical study to explore the effectiveness of selected siddha drugs for Vathakarsanam(Diabetic Peripheral Neuropathy) through MNSI (score and questionnaire ) at Ayothidoss Pandithar Hospital , NIS - Nil
I0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •NIDDN(Non Insulin Dependent Diabetic Medication) Glycated Hemoglobin 7% TO 10%
- •Michigan Neuropathy Screening Instrument (MNSI)-Examination Score 2.5/5 and MNSI Questionnaire Score 7/15 Consider Positive for the presence of Neuropathy
- •Known Diabetes Participants Already on OHAs With or without medication for more than 5 years with Numbness,Burning sensation of foot and Pricking Pain in both Leg and Foot and toes.
Exclusion Criteria
- •IDDM(Insulin Dependent Diabetes Mellitus)
- •Secondary Uncontrolled Hypertension (150 TO 90 MM HG)
- •Vitamin B12 Deficiency
- •CVA,Old CVA,Seizure disorder
- •Gestational Diabetes Mellitus
- •CKA and AKD Participants
- •Varicose Veins, Non Healing Ulcers,Amputation/Surgery in Lower Limb
- •Participans with lumbosacral radiculopathy testing Positive for Straight Leg Raising and Las Segue Sign
Investigators
Similar Trials
Not yet recruiting
Unknown
A trial to explore the effectiveness of siddha treatment for pakkavatham ( Hemiplegic stroke)CTRI/2023/09/057216il
Not yet recruiting
Unknown
Clinical trial to evaluate efficacy of chitramutti madakku thailam peechu therapy in the management of thandagavathsmCTRI/2023/10/058490nil
Recruiting
Phase 2
Clinical study on sleep tablets in sleep problemCTRI/2024/03/063637SciTech Specialties Pvt. Ltd.
Not yet recruiting
Phase 2
Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)CTRI/2023/09/057492I
Completed
Not Applicable
To evaluate clinical efficacy and safety of autologous serum injection therapyDiseases of the skin and subcutaneous tissueKCT0001971Ajou University Hospital50